Precision Nanomedicine

AIBN researchers have won funding to examine if particles in our muscles could unlock new treatments for Motor Neurone Disease.

New nanotechnology from the AIBN labs could help an emerging and non-invasive cancer treatment become even more effective.

Associate Professor Joy Wolfram has won funding to help patients bounce back more effectively after open-heart surgery.

Researchers from the AIBN have made a significant step towards enabling women with epilepsy safer access to a common anti-seizure medication.

Dr Samantha Stehbens says a cell's journey through crowded tissue environments remains shrouded in mystery. In Nature Cell Biology, she may have some new answers.

A new nanodevice designed by AIBN researchers analyses sugars on the surface of cellular messenger particles to catch early signs of lung cancer.

A first of its kind brain organoid grown at The University of Queensland has helped researchers identify therapies that reduce the impact of COVID-19 on people with Down syndrome.

AIBN researchers scored four wins in the latest Investigator Grant round for nanotechnology projects that could change the way we approach certain diseases.

Work on a new range of hyper accurate cancer drugs has begun with the launch of an Australian-first research and manufacturing hub.

AIBN Associate Professor Joy Wolfram believes decoding a cellular messaging system will give them the upper hand against a particularly deadly type of breast cancer.